Trials (Jun 2020)
Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)
- Toshinari Yamashita,
- Norikazu Masuda,
- Shigehira Saji,
- Kazuhiro Araki,
- Yoshinori Ito,
- Toshimi Takano,
- Masato Takahashi,
- Junji Tsurutani,
- Kei Koizumi,
- Masahiro Kitada,
- Yasuyuki Kojima,
- Yasuaki Sagara,
- Hiroshi Tada,
- Tsutomu Iwasa,
- Takayuki Kadoya,
- Tsuguo Iwatani,
- Hiroki Hasegawa,
- Satoshi Morita,
- Shinji Ohno
Affiliations
- Toshinari Yamashita
- Department of Breast Surgery, Kanagawa Cancer Center
- Norikazu Masuda
- Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital
- Shigehira Saji
- Department of Medical Oncology, Fukeushima Medical University
- Kazuhiro Araki
- Department of Breast Surgery, Gunma Prefectural Cancer Center
- Yoshinori Ito
- Breast Medical Oncology, Breast Oncology Center, The Cancer Institute Hospital of JFCR
- Toshimi Takano
- Department of Medical Oncology, Toranomon Hospital
- Masato Takahashi
- Breast Surgery, NHO Hokkaido Cancer Center
- Junji Tsurutani
- Department of Medical Oncology, Showa University Hospital
- Kei Koizumi
- First Department of Surgery, Hamamatsu University School of Medicine
- Masahiro Kitada
- Breast Disease Center, Asahikawa Medical University Hospital
- Yasuyuki Kojima
- Department of Breast Surgery, St. Marianna University School of Medicine Hospital
- Yasuaki Sagara
- Breast Surgical Oncology, Sagara Hospital
- Hiroshi Tada
- Department of Breast and Endocrine Surgical Oncology, Tohoku University Hospital
- Tsutomu Iwasa
- Oncology Internal Medicine, Kindai University Hospital
- Takayuki Kadoya
- Breast Surgery, Hiroshima University Hospital
- Tsuguo Iwatani
- Department of Breast Surgery, National Cancer Center Hospital East
- Hiroki Hasegawa
- Eisai Co., Ltd.
- Satoshi Morita
- Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine Kyoto University
- Shinji Ohno
- Breast Oncology Center, The Cancer Institute Hospital of JFCR
- DOI
- https://doi.org/10.1186/s13063-020-04408-w
- Journal volume & issue
-
Vol. 21,
no. 1
pp. 1 – 2
Abstract
An amendment to this paper has been published and can be accessed via the original article.
